Melittin‐Loaded Multifunctional Nanozyme for Ulcerative Colitis Treatment via Enzyme‐Immunotherapy and Ferroptosis Inhibition
Source abstract
Abstract
Abstract In ulcerative colitis (UC), oxidative stress (OS) and iron overload disrupt immune homeostasis and intestinal barrier function, exacerbating inflammation through effects on macrophages and intestinal epithelial cells (IECs). Reversing macrophage‐driven inflammation and restoring homeostasis of IECs are effective strategies for treating UC. In this study, a multifunctional nanozyme (PDA‐Rh@Mel) is reported consisting of polydopamine nanoparticles (PDA) as the core, in situ‐grown rhodium (Rh) aggregates, and loaded melittin (Mel). PDA‐Rh@Mel efficiently aggregates at the site of inflammation through electrostatic interactions, exhibits cascading enzyme catalytic activity to reduce OS, and performs macrophage reprogramming. By chelating iron ions, scavenging reactive oxygen and nitrogen species, and protecting mitochondria, PDA‐Rh@Mel maintains homeostasis of IECs, preventing further barrier damage and exacerbation of UC. Network pharmacological and histological evaluations show that PDA‐Rh@Mel alleviated symptoms by inhibiting the IL‐17 signaling pathway. These findings demonstrate that PDA‐Rh@Mel can maintain redox balance, iron homeostasis, and immune equilibrium, representing a highly promising therapeutic strategy for UC.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics · Extracellular vesicles in disease
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Chongqing Research Center for Pharmaceutical Engineering Center for Pharmaceutical Development and Nanomedicine College of Pharmacy Chongqing Medical University Chongqing 400016 China
Funding
National Natural Science Foundation of China · Natural Science Foundation of Chongqing Municipality
References (61)
Show source-provided references
1. 10.1016/S0140-6736(23)00966-210.1016/S0140-6736(23)00966-2 ↗
2. 10.1038/nrgastro.2016.20810.1038/nrgastro.2016.208 ↗
3. 10.1038/s41575-023-00854-410.1038/s41575-023-00854-4 ↗
4. 10.1016/j.molmed.2023.01.00110.1016/j.molmed.2023.01.001 ↗
5. 10.1038/s41467-023-39173-210.1038/s41467-023-39173-2 ↗
6. 10.7150/thno.7066810.7150/thno.70668 ↗
7. 10.1021/acsnano.3c0655110.1021/acsnano.3c06551 ↗
8. 10.1053/j.gastro.2024.01.05110.1053/j.gastro.2024.01.051 ↗
9. 10.1186/s12951-024-02861-210.1186/s12951-024-02861-2 ↗
10. 10.1016/j.ajps.2023.10083110.1016/j.ajps.2023.100831 ↗
11. 10.1038/s41575-024-01035-710.1038/s41575-024-01035-7 ↗
12. 10.1053/j.gastro.2024.10.00110.1053/j.gastro.2024.10.001 ↗
13. 10.1146/annurev-med-052919-12004810.1146/annurev-med-052919-120048 ↗
14. 10.1039/c3cs35486e10.1039/c3cs35486e ↗
15. 10.1021/accountsmr.3c0023010.1021/accountsmr.3c00230 ↗
16. 10.1002/adfm.20211043210.1002/adfm.202110432 ↗
17. 10.1002/adhm.20240163010.1002/adhm.202401630 ↗
18. 10.1002/cjoc.20230075510.1002/cjoc.202300755 ↗
19. 10.1002/adma.20240565510.1002/adma.202405655 ↗
20. 10.1021/acsnano.2c0342210.1021/acsnano.2c03422 ↗
21. 10.1002/anie.20220110110.1002/anie.202201101 ↗
22. 10.1002/adfm.20231352810.1002/adfm.202313528 ↗
23. 10.1016/j.nantod.2024.10224110.1016/j.nantod.2024.102241 ↗
24. 10.1002/smll.20230234710.1002/smll.202302347 ↗
25. 10.1016/j.jconrel.2022.12.05210.1016/j.jconrel.2022.12.052 ↗
26. 10.1016/j.jconrel.2023.01.04710.1016/j.jconrel.2023.01.047 ↗
27. 10.1002/adfm.20210247210.1002/adfm.202102472 ↗
28. 10.1002/adfm.20200469210.1002/adfm.202004692 ↗
29. 10.1002/adhm.20240004810.1002/adhm.202400048 ↗
30. 10.1126/sciadv.abb269510.1126/sciadv.abb2695 ↗
31. 10.1016/j.actbio.2023.02.02610.1016/j.actbio.2023.02.026 ↗
32. 10.1186/s12951-024-02539-910.1186/s12951-024-02539-9 ↗
33. 10.1016/j.cclet.2024.11021110.1016/j.cclet.2024.110211 ↗
34. 10.1038/s41580-020-00324-810.1038/s41580-020-00324-8 ↗
35. 10.1038/s41556-024-01425-810.1038/s41556-024-01425-8 ↗
36. 10.1016/j.apsb.2024.05.02510.1016/j.apsb.2024.05.025 ↗
37. 10.1016/j.bioactmat.2023.09.02010.1016/j.bioactmat.2023.09.020 ↗
38. 10.1016/j.bios.2022.11412710.1016/j.bios.2022.114127 ↗
39. 10.1002/smll.20220696010.1002/smll.202206960 ↗
40. 10.1002/advs.20220721610.1002/advs.202207216 ↗
41. 10.1021/acsami.1c1806110.1021/acsami.1c18061 ↗
42. 10.1002/adhm.20240161310.1002/adhm.202401613 ↗
43. 10.1186/s12951-023-02223-410.1186/s12951-023-02223-4 ↗
44. 10.1016/j.jconrel.2021.07.00510.1016/j.jconrel.2021.07.005 ↗
45. 10.1002/advs.20220418410.1002/advs.202204184 ↗
46. 10.1038/s41467-021-24447-410.1038/s41467-021-24447-4 ↗
47. 10.1016/j.cej.2025.16097210.1016/j.cej.2025.160972 ↗
48. 10.1186/s12951-023-02026-710.1186/s12951-023-02026-7 ↗
49. 10.1016/j.cej.2022.14049810.1016/j.cej.2022.140498 ↗
50. 10.1021/acs.nanolett.9b0503510.1021/acs.nanolett.9b05035 ↗
51. 10.7150/thno.9603810.7150/thno.96038 ↗
52. 10.1016/j.nantod.2024.10215510.1016/j.nantod.2024.102155 ↗
53. 10.1038/s41586-023-06142-010.1038/s41586-023-06142-0 ↗
54. 10.1038/s41590-021-01090-110.1038/s41590-021-01090-1 ↗
55. 10.1002/adma.20250193310.1002/adma.202501933 ↗
56. 10.1016/j.phrs.2023.10664510.1016/j.phrs.2023.106645 ↗
57. 10.1186/s12951-022-01299-810.1186/s12951-022-01299-8 ↗
58. 10.1038/s41467-021-22641-y10.1038/s41467-021-22641-y ↗
59. 10.1016/j.immuni.2021.03.01810.1016/j.immuni.2021.03.018 ↗
60. 10.1016/j.ebiom.2024.10512810.1016/j.ebiom.2024.105128 ↗
61. 10.1016/j.biopha.2022.11294810.1016/j.biopha.2022.112948 ↗